| Dec 2, 2025 | Ripple Foods | $17.0M Other Equity | — | Tim Koogle, Fall Line Capital, Melissa Fensterstock, Prelude Ventures, Rich Products Ventures, S2G Ventures, Tao Capital Partners |
| Aug 1, 2025 | SetPoint Medical | $120.0M Series D | Kevin Reilly, Josh Makower | Action Potential Venture Capital, Morgenthaler Ventures, New Enterprise Associates (NEA), Norwest Venture Partners, Runway Growth Capital, Shangbay Capital, Abbott, Ascendum Capital, Boston Scientific, Catalio Capital Management, Gilmartin Capital, Midas Capital, Morgenthaler Ventures, New Enterprise Associates, Northwell Health, Norwest Venture Partners, Richard King Mellon Foundation, SPRIG Equity, Viking Global Investors |
| Jun 1, 2025 | Actio Biosciences | $66.0M Series B | Deerfield Management, Regeneron Ventures | Canaan Partners, Canaan Partners, Droia Ventures |
| Oct 30, 2024 | Leal Therapeutics | $45.0M Other Equity | Thomas Cahill | Alexandria Venture Investments, John Gustofson, OrbiMed, PhiFund Ventures |
| Mar 1, 2024 | FundGuard | $100.0M Series C | Amit Pilowsky | Hanaco Ventures, IGNIA Partners, Mouro Capital, Pitango Venture Capital, Quona Capital, Team8, Vertex Ventures Israel, Flavio Dias, Paulo Piccini, Blumberg Capital, Hamilton Lane |
| Feb 1, 2024 | Kenai Therapeutics | $82.0M Series A | Cure Ventures, The Column Group, Alaska Permanent Fund | Saisei Ventures |
| Jan 1, 2024 | Sion Power | $75.0M Series A | Hansol Kim, Robert McIntyre | Andreessen Horowitz, E1 Ventures, General Catalyst, Christian Miele, Index Ventures, Innovation Endeavors, Kima Ventures, Motier Ventures, Quassar Capital, Anjney Midha, Jim Simons, Eric Schmidt |
| Sep 1, 2023 | Actio Biosciences | $55.0M Series A | Nina Kjellson, George Golumbeski | Canaan Partners, Deerfield Management, Alex Tkachenko |
| Mar 1, 2023 | Spiral | $28.0M Series A | Team8 | Accel, Cyberstarts VC, Glilot Capital Partners, Insight Partners, Scale Asia Ventures, Tamar Technology Ventures, Benny Schnaider, Efi Cohen, Communitas Capital, Intuition Fund, Nidoco, Phoenix |
| Feb 1, 2023 | Codagenix | $25.0M Series B | Adjuvant Capital, Serum Institute of India | IST cube, Kimberly Vogel |
| Nov 1, 2022 | Casma Therapeutics | $46.0M Series C | — | Astellas Venture Management, The Column Group, Third Rock Ventures, Amgen Ventures, Hiromichi Kimura, Eisai, Eventide Asset Management, Mirae Asset, Tomotaka Okino, Schroders Capital |
| Sep 1, 2022 | Redesign Health | $65.0M Series C | General Catalyst | BoxGroup, FirstMark Capital, First Round Capital, Montauk Ventures, Seven Seven Six, SignalFire, Sinai Ventures, Marco DeMeireles, Torch Capital, Tusk Venture Partners, Vine Ventures LP, Y Combinator, Karim Atiyeh, Scott Belsky, CVS Health Ventures, Declaration Partners, Eden Global Partners, Samsung Next, TriplePoint Capital, UPMC Enterprises |
| Jun 1, 2022 | April | $30.0M Series A | Eli Broverman | Team8, Shai Wininger, Atento Capital, Nyca Partners, QED |
| Feb 1, 2022 | Kallyope | $240.0M Series D | The Column Group | Andreessen Horowitz, Contrarian Ventures, INKEF Capital, Lux Capital, Mosaic Ventures, PentaLab, Union Square Ventures, Wind Ventures, Bill Gates, Alexandria Venture Investments, Casdin Capital, DNS Capital, Hartford HealthCare Endowment, Illumina Ventures, Parkwood, Polaris Partners, StepStone Group, Tao Capital, Two Sigma Ventures |
| Oct 26, 2021 | DroneBase | $20.0M Other Equity | Euclidean Capital | — |
| Oct 5, 2021 | Duality | $30.0M Series B | Taejoon Park | Hearst Ventures, Intel Capital, NAventures, Team8 |
| Oct 1, 2021 | Duality Technologies | $30.0M Series B | LG Technology Ventures | Ashvin Chhabra, Hearst Ventures, Roi Bar-Kat, NAventures, Team8 |
| Jul 14, 2021 | Ribon Therapeutics | $65.0M Other Equity | Cameron Wheeler, U.S. Venture Partners | AbbVie Ventures, Avego Bioscience Capital, Bristol Myers Squibb, Google Ventures, Johnson & Johnson Innovation, Monashee Investment Management, Novartis, Osage University Partners, Peregrine Ventures, Takeda Ventures, The Column Group |
| Jun 1, 2021 | Stablix | $63.0M Series A | Versant Ventures | Access Biotechnology, Tak Cheung, New Enterprise Associates, Polaris Partners, SR One, Vensana Capital, Alexandria Venture Investments, Cormorant Asset Management, Ali Behbahani |
| May 1, 2021 | ASAPP | $120.0M Series C | Dragoneer Investment Group, Fidelity Management & Research Company | Andreessen Horowitz, Arkitekt Ventures, Benhamou Global Ventures, Compound, Emergence Capital, Great Wave Ventures, Kleiner Perkins, Toyota Ventures, Uday Sandhu, John Chambers, John Doerr, 40 North Ventures, HOF Capital, March Capital, Telstra Ventures |
| Jan 1, 2021 | SetPoint Medical | $64.0M Series B | Josh Makower | Action Potential Venture Capital, Morgenthaler Ventures, New Enterprise Associates (NEA), Norwest Venture Partners, Runway Growth Capital, Shangbay Capital, Aethan Capital, Asahi Kasei, Ascendum Capital, Banyan Pacific Capital, Boston Scientific, Catalio Capital Management, Citta Capital, Midas Capital, Morgenthaler Ventures, Revelation Partners, Richard King Mellon Foundation, SVE Capital, Topspin Fund |
| Jun 1, 2020 | Surrozen | $50.0M Series C | — | Canaan Partners, The Column Group, Hartford HealthCare, Horizons Ventures |
| Apr 30, 2020 | Dascena | $50.0M Series B | Frazier Healthcare Partners | Longitude Capital |
| Apr 1, 2020 | ASAPP | $190.0M Series B | — | 83North, Angular Ventures, Arkitekt Ventures, Compound, G20 Ventures, Great Wave Ventures, Greylock, Kleiner Perkins, Dave Strohm, Joe Tucci, John Chambers, John Doerr, Emergence Capital, HOF Capital, March Capital, Telstra Ventures, Vast Ventures |
| Mar 1, 2020 | Kallyope | $110.0M Series C | — | Andreessen Horowitz, Contrarian Ventures, INKEF Capital, Lux Capital, Mosaic Ventures, PentaLab, Union Square Ventures, Wind Ventures, Bill Gates, Alexandria Venture Investments, Casdin Capital, Greenspring Associates, Illumina Ventures, Polaris Partners, The Column Group, Two Sigma Ventures |
